Simtra BioPharma Solutions
Contract manufacturer of sterile injectable drug products for pharmaceuticals.
Company facts
- Founded
- 1950
- Employees
- 1,700
- Headquarters
- United States
- CEO
- Franco Negron
- Type
- Private
- Funding
- Private Equity · $4.3B · 2023
- Subsidiaries
- Baxter Oncology GmbH, Simtra US LLC
About
At Simtra BioPharma Solutions, we’re passionate about developing and manufacturing high-quality sterile injectable products tailored to ever-evolving patient needs. With over 65 years of experience, we have built a reputation as a premier contract development and manufacturing organization (CDMO), with a focus on collaboration and integrity. Our extensive knowledge in sterile manufacturing ensures we meet the highest industry standards, empowering our clients to succeed in their therapeutic ventures. Our offerings span the entire lifecycle of pharmaceutical development, providing services that include formulation development, analytical testing, support for regulatory compliance, and fill/finish operations. We pride ourselves on our flexible manufacturing processes that cater to a wide variety of drug categories, such as biologics, vaccines, cytotoxics, and more. By partnering with us, our clients gain access to tailored solutions that address their unique challenges, allowing them to bring life-changing medicines to market more efficiently and effectively. Every medication we manufacture is created with care, precision, and a commitment to quality, ensuring patients around the globe receive the best possible care.